Malta needs a simpler and more practical medicines registration system, that addresses the quality, safety and efficacy of medications on the market without, however, decreasing the availability of products, according to a representation to Maltese Prime Minister Lawrence Gonzi by the pharmaceutical section of the Malta Chamber for Small and Medium Enterprises (GRTU), reported by Malta Media news.
Pharmaceutical section president Mario Debono presented the PM with an independent study commissioned by the GRTU, which addressed the concerns of all pharmaceutical wholesalers, distributors and pharmacies who are members of the Chamber. In a statement, the GRTU declared it believed that its members' position has now been understood by the government.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze